Eli Lilly & Co.

$1,070.9
USD
Last updated on --.
24h volume2.85M
24h highest1,082.00 USD
24h lowest1,060.36 USD
24h Price movement+0.55%

LLY recent prices

24 Hours
+0.55%+$5.900
30 days
+23.88%+$207.30
60 days
+21.27%+$186.76
90 days
+5.24%+$53.55

Key data

Previous close1,065.00 USD
Market cap908.57B USD
Volume2.85M
P/E ratio35.940000
Dividend yield (TTM)0.01%
Dividend amount1.7300 USD
Next ex-dividend dateMay 15, 2026
Next payment dateJun 10, 2026
EPS diluted (TTM)28.3500 USD
Net income (FY)25.28B USD
Revenue (FY)72.25B USD
Last report dateApr 30, 2026

About Eli Lilly & Co.

PHARMACEUTICAL PREPARATIONS
HeadquartersINDIANAPOLIS
Employees (FY)50.00K
Revenue per employee (FY)1.44M USD
Net income per employee (FY)505.53K USD
Listed onNew York Stock Exchange
Official website

LLY conversion tables

LLYLLY
USDUSD
0.5 LLY535.45 USD
1 LLY1,070.9 USD
5 LLY5,354.5 USD
10 LLY10,709 USD
USDUSD
LLYLLY
0.5 USD0.0004669 LLY
1 USD0.00093379 LLY
5 USD0.004669 LLY
10 USD0.0093379 LLY

FAQ

LLY is trading at $1.07K, +0.55% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LLY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LLY is currently trading at $1.07K, +0.55% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LLY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LLY's P/E ratio is currently 35.940000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LLY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LLY's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Eli Lilly & Co.'s market cap is currently 908.57B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.85M
24h highest1,082.00 USD
24h lowest1,060.36 USD
24h Price movement+0.55%
LLYLLY
USDUSD
Start trade with LLY Perpetual